NCT01424449 - A PET Study in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Depressive Disorder

Interventions

RADIATION

[11C]PHNO

examine the effects of \[11C\]PHNO mass carry-over and displaceable binding

DRUG

Aripiprazole

A 4th scan will follow a 15mg dose of aripiprazole (a D2/D3 compound which allows the highest clinically acceptable blockade of central D2/D3 receptors)

Trial Locations (1)

W12 ONN

GSK Investigational Site, London